Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Giuseppe Giaccone, Chul Kim, Jillian Thompson, Colleen McGuire, Bhaskar Kallakury, Joeffrey J Chahine, Maria Manning, Robin Mogg, Wendy M Blumenschein, Ming T Tan, Deepa S Subramaniam, Stephen V Liu, Ian M Kaplan, Justine N McCutcheon Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA (Prof G Giaccone MD,C Kim MD, J Thompson MSN,C McGuire MSN,Prof B Kallakury MD,J J Chahine MS, M Manning MD, Prof M T Tan PhD,D S Subramaniam MD, S V Liu MD, J N McCutcheon BS); Merck and Co, Kenilworth, NJ, USA (R Mogg PhD, W M Blumenschein BA); and Adaptive Biotechnologies, Seattle, WA, USA(I M Kaplan PhD)